[
    [
        {
            "time": "",
            "original_text": "【民生医药|周报】CXO回调，更加重视中国市场红利对边际的改善",
            "features": {
                "keywords": [
                    "CXO",
                    "回调",
                    "中国市场",
                    "红利",
                    "边际改善"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【民生医药|周报】CXO回调，更加重视中国市场红利对边际的改善",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]